Clinical Nutrition: Global Markets to 2031
| 出版 | BCC Research |
| 出版年月 | 2026年06月 |
| ページ数 | 185 |
| 価格 | 記載以外のライセンスについてはお問合せください |
| シングルユーザ | USD 4,650 |
| 種別 | 英文調査報告書 |
| 商品番号 | SMR-24393 |
世界の臨床栄養市場は、2026年の795億ドルから成長し、2026年から2031年の予測期間中に年平均成長率（CAGR）5.6%で推移して、2031年末には1,047億ドルに達するとBCC Researchでは予測しています。
本レポートの主な内容
- 78のデータ表および43の追加表
- 現在の市場規模や将来の成長性を含む、臨床栄養市場の分析
- 2025年（基準年）の市場規模推計および2026年から2031年までの市場予測
- タイプ別およびエンドユーザー別による市場の詳細なセグメンテーション
- 市場の成長に影響を与える主な促進要因、阻害要因、および機会の分析
- 業界動向、新興技術、特許分析、および臨床栄養分野における開発状況に関する考察
- 主要地域における規制環境の評価
- 北米、欧州、アジア太平洋、その他の地域を含む各地域市場の分析
- 市場シェア、ランキング、製品マッピング分析、主要企業の戦略的動向を含む競争環境の分析
- 主要企業および新興企業のプロファイル（製品ポートフォリオ、財務情報、最近の動向など）。対象企業：ネスレ（Nestlé）、ダノン（Danone）、アボット（Abbott）、レキット（Reckitt）、大塚ホールディングス、フレゼニウス・カビ（Fresenius Kabi AG）など
本レポートは、世界の臨床栄養市場に関する詳細な情報を提供するものです。2025年のデータ、2026年の推定値、2031年までの年平均成長率（CAGR）の予測（予測期間：2026年～2031年）、および地域別の市場動向を分析しています。また、臨床栄養市場の現在および将来の潜在性を強調し、競争環境についても詳細に分析しています。さらに、規制状況、市場の促進要因、阻害要因、機会についても取り上げています。加えて、2031年までの市場予測や主要企業の市場シェアも掲載しています。
本レポートにおける市場の範囲は、栄養の種類（乳児用栄養、経腸栄養、経静脈栄養）およびエンドユーザー（乳児、小児、成人、高齢者）に基づいて区分されています。
市場は、北米、欧州、アジア太平洋、中東・アフリカ、南米といった主要地域に区分されています。地域別の区分では、米国、カナダ、メキシコ、ドイツ、英国、フランス、イタリア、スペイン、日本、中国、韓国、オーストラリア、インドなどの主要国に関する詳細な分析を行っています。市場の推定値については、基準年である2025年のデータに加え、2026年の予測値および2031年の予測値が示されています。
Report Highlights
The global market for clinical nutrition is expected to grow from $79.5 billion in 2026 and is projected to reach $104.7 billion by the end of 2031, at a compound annual growth rate (CAGR) of 5.6% during the forecast period of 2026 to 2031.
Report Includes
- 78 data tables and 43 additional tables
- Analysis of the clinical nutrition market, including current market size and future growth potential
- Market size estimates for 2025 (base year) and forecasts for the period 2026 through 2031
- Detailed segmentation of the market by type and end user
- Analysis of key market drivers, restraints, and opportunities influencing market growth
- Insights into industry trends, emerging technologies, patent analysis and developments in clinical nutrition
- Evaluation of the regulatory landscape across major regions
- Analysis of regional markets, including North America, Europe, Asia-Pacific and Rest of the World
- Competitive landscape analysis, including market share, ranking, product mapping analysis and strategic developments of key players
- Profiles of leading and emerging companies, including their product portfolios, financials, and recent developments, including Nestlé, Danone, Abbott, Reckitt, Otsuka Holdings Co. Ltd., and Fresenius Kabi AG
Report Scope
This report provides detailed information on the global clinical nutrition market. It analyzes market trends in clinical nutrition using data from 2025, estimates for 2026, projections of compound annual growth rates through 2031 (forecast period 2026–2031), and regional clinical nutrition markets. This report highlights clinical nutrition’s current and future market potential and provides a detailed analysis of the competitive environment. The report covers regulatory scenarios, drivers, restraints, and opportunities. The report also covers market projections for 2031 and the market share for key market companies.
The market scope in this report is segmented by nutrition type into infant nutrition, enteral nutrition, and parenteral nutrition. The market scope in this report is segmented by end users, which includes infants, children, adults, and geriatrics.
The market has been segmented into significant geographies: North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The regional segment covers a detailed analysis of major countries such as the U.S., Canada, Mexico, Germany, the U.K., France, Italy, Spain, Japan, China, South Korea, Australia, and India. For market estimates, data is provided for 2025 because of the base year, with forecasts for 2026 and a forecast value for 2031.
The report aims to:
- Analyze types of clinical nutrition.
- Analyze global market size and segmentation.
- Understand market constraints and drivers.
- Provide detailed market forecasts for 2030.
- Assess market shares, competitiveness, and industry structure.
- Identify potential long-term impacts on the global clinical nutrition market.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2025 | ||||||||||||||||
| Forecast period considered | 2026-2031 | ||||||||||||||||
| Base year market size | $75.5 Billion | ||||||||||||||||
| Market size forecast | $104.7 Billion | ||||||||||||||||
| Growth rate | CAGR of 5.6% for the forecast period of 2026-2031 | ||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||
| Segments covered | Nutrition Type, End User, and Region | ||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, South America and Middle East and Africa | ||||||||||||||||
| Countries covered | U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Australia, Brazil, and Argentina | ||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||
| Companies studied |
|
||||||||||||||||
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Market Dynamics and Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Conclusion
Chapter 2 Market Overview
Overview
Macroeconomic Factor Analysis
Healthcare Expenditure
Geopolitical Risks, Trade Wars, and Supply Chain Disruptions
Aging Population
Porter’s Five Forces Analysis
Bargaining Power of Buyers
Bargaining Power of Suppliers
Potential for New Entrants
Threat of Substitutes
Competitiveness in the Industry
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Increasing Incidence of Preterm Births Worldwide
Malnutrition in Infants and the Geriatric Population
Rising Cases of Chronic Diseases
Market Restraints
Breast Milk Debate
Product Recalls
Reimbursement Issues
Market Opportunities
Malnutrition in Oncology Patients
Emerging Markets
Chapter 4 Regulatory Landscape
Overview
U.S.
Europe
Asia-Pacific
Chapter 5 Emerging Technologies and Pipeline Analysis
Overview
Artificial Intelligence (AI)
Nutrigenomics
Clinical Trial Analysis
Clinical Trials Analysis by Type of Study
Clinical Trials Analysis by Status
Clinical Trials Analysis by Phase
Patent Analysis
Patents by Top Applicant
Patents by Jurisdiction
Key Takeaways
Chapter 6 Market Segmentation Analysis
Segmentation Breakdown
Global Market for Clinical Nutrition, by Nutrition
Key Takeaways
Infant Nutrition
Enteral Nutrition
Parenteral Nutrition
Global Clinical Nutrition Market, by End User
Key Takeaways
Infants
Geriatrics
Children
Adults
Geographic Breakdown
Global Market for Clinical Nutrition, by Region
Key Takeaways
North America
Europe
Asia-Pacific
Middle East and Africa
South America
Chapter 7 Competitive Intelligence
Key Takeaways
Competitive Landscape
Company Share Analysis
Chapter 8 Appendix
Methodology
Abbreviations
Sources
Company Profiles
ABBOTT
BAXTER
B. BRAUN SE
DANONE
DSM-FIRMENICH
FRESENIUS KABI AG
GLANBIA PLC
INTERNATIONAL FLAVORS & FRAGRANCES INC.
LONZA
MEIJI HOLDINGS CO. LTD.
NESTLE
OTSUKA HOLDINGS CO. LTD.
PERRIGO CO. PLC
PROLACTA
RECKITT
Emerging Companies in the Global Clinical Nutrition Market
List of Tables
Summary Table : Global Market for Clinical Nutrition, by Region, Through 2031
Table 1 : Current Health Expenditure
Table 2 : Rheumatoid Arthritis – Level 3 Cause, 2021
Table 3 : Global HIV Epidemic, by Age Group, 2023
Table 4 : Clinical Trials in Clinical Nutrition, by Type of Study, as of April 2026
Table 5 : Clinical Trials in Clinical Nutrition, by Status, as of April 2026
Table 6 : Clinical Trials in Clinical Nutrition, by Phase, as of April 2026
Table 7 : Patents Granted for Clinical Nutrition, by Top Applicant
Table 8 : Patents Granted for Clinical Nutrition, by Jurisdiction
Table 9 : Global Market for Clinical Nutrition, by Type of Nutrition, Through 2031
Table 10 : Global Market for Infant Nutrition in Clinical Nutrition, by Region, Through 2031
Table 11 : Global Market for Infant Nutrition in Clinical Nutrition, by Type, Through 2031
Table 12 : Global Market for Enteral Nutrition in Clinical Nutrition, by Region, Through 2031
Table 13 : Global Market for Enteral Nutrition in Clinical Nutrition, by Type, Through 2031
Table 14 : Global Market for Parenteral Nutrition in Clinical Nutrition, by Region, Through 2031
Table 15 : Global Market for Parenteral Nutrition in Clinical Nutrition, by Type, Through 2031
Table 16 : Global Market for Clinical Nutrition, by End User, Through 2031
Table 17 : Global Market for Clinical Nutrition for Infants, by Region, Through 2031
Table 18 : Global Market for Clinical Nutrition for Geriatrics, by Region, Through 2031
Table 19 : Global Market for Clinical Nutrition for Children, by Region, Through 2031
Table 20 : Global Market for Clinical Nutrition for Adults, by Region, Through 2031
Table 21 : Global Market for Clinical Nutrition, by Region, Through 2031
Table 22 : North American Market for Clinical Nutrition, by Type of Nutrition, Through 2031
Table 23 : North American Market for Clinical Nutrition, by End User, Through 2031
Table 24 : North American Market for Clinical Nutrition, by Country, Through 2031
Table 25 : U.S. Market for Clinical Nutrition, by Type of Nutrition, Through 2031
Table 26 : U.S. Market for Clinical Nutrition, by End User, Through 2031
Table 27 : Canadian Market for Clinical Nutrition, by Type of Nutrition, Through 2031
Table 28 : Canadian Market for Clinical Nutrition, by End User, Through 2031
Table 29 : Mexican Market for Clinical Nutrition, by Type of Nutrition, Through 2031
Table 30 : Mexican Market for Clinical Nutrition, by End User, Through 2031
Table 31 : European Market for Clinical Nutrition, by Type of Nutrition, Through 2031
Table 32 : European Market for Clinical Nutrition, by End User, Through 2031
Table 33 : European Market for Clinical Nutrition, by Country, Through 2031
Table 34 : German Market for Clinical Nutrition, by Type of Nutrition, Through 2031
Table 35 : German Market for Clinical Nutrition, by End User, Through 2031
Table 36 : U.K. Market for Clinical Nutrition, by Type of Nutrition, Through 2031
Table 37 : U.K. Market for Clinical Nutrition, by End User, Through 2031
Table 38 : French Market for Clinical Nutrition, by Type of Nutrition, Through 2031
Table 39 : French Market for Clinical Nutrition, by End User, Through 2031
Table 40 : Italian Market for Clinical Nutrition, by Type of Nutrition, Through 2031
Table 41 : Italian Market for Clinical Nutrition, by End User, Through 2031
Table 42 : Spanish Market for Clinical Nutrition, by Type of Nutrition, Through 2031
Table 43 : Spanish Market for Clinical Nutrition, by End User, Through 2031
Table 44 : Rest of Europe Market for Clinical Nutrition, by Type of Nutrition, Through 2031
Table 45 : Rest of Europe Market for Clinical Nutrition, by End User, Through 2031
Table 46 : Asia-Pacific Market for Clinical Nutrition, by Type of Nutrition, Through 2031
Table 47 : Asia-Pacific Market for Clinical Nutrition, by End User, Through 2031
Table 48 : Asia-Pacific Market for Clinical Nutrition, by Country, Through 2031
Table 49 : Chinese Market for Clinical Nutrition, by Type of Nutrition, Through 2031
Table 50 : Chinese Market for Clinical Nutrition, by End User, Through 2031
Table 51 : Japanese Market for Clinical Nutrition, by Type of Nutrition, Through 2031
Table 52 : Japanese Market for Clinical Nutrition, by End User, Through 2031
Table 53 : Indian Market for Clinical Nutrition, by Type of Nutrition, Through 2031
Table 54 : Indian Market for Clinical Nutrition, by End User, Through 2031
Table 55 : South Korean Market for Clinical Nutrition, by Type of Nutrition, Through 2031
Table 56 : South Korean Market for Clinical Nutrition, by End User, Through 2031
Table 57 : Australian Market for Clinical Nutrition, by Type of Nutrition, Through 2031
Table 58 : Australian Market for Clinical Nutrition, by End User, Through 2031
Table 59 : Rest of Asia-Pacific Market for Clinical Nutrition, by Type of Nutrition, Through 2031
Table 60 : Rest of Asia-Pacific Market for Clinical Nutrition, by End User, Through 2031
Table 61 : Middle East and African Market for Clinical Nutrition, by Type of Nutrition, Through 2031
Table 62 : Middle East and African Market for Clinical Nutrition, by End User, Through 2031
Table 63 : Middle East and African Market for Clinical Nutrition, by Country, Through 2031
Table 64 : Middle Eastern Market for Clinical Nutrition, by Type of Nutrition, Through 2031
Table 65 : Middle Eastern Market for Clinical Nutrition, by End User, Through 2031
Table 66 : African Market for Clinical Nutrition, by Type of Nutrition, Through 2031
Table 67 : African Market for Clinical Nutrition, by End User, Through 2031
Table 68 : South American Market for Clinical Nutrition, by Type of Nutrition, Through 2031
Table 69 : South American Market for Clinical Nutrition, by End User, Through 2031
Table 70 : South American Market for Clinical Nutrition, by Country, Through 2031
Table 71 : Brazilian Market for Clinical Nutrition, by Type of Nutrition, Through 2031
Table 72 : Brazilian Market for Clinical Nutrition, by End User, Through 2031
Table 73 : Argentine Market for Clinical Nutrition, by Type of Nutrition, Through 2031
Table 74 : Argentine Market for Clinical Nutrition, by End User, Through 2031
Table 75 : Rest of South America Market for Clinical Nutrition, by Type of Nutrition, Through 2031
Table 76 : Rest of South America Market for Clinical Nutrition, by End User, Through 2031
Table 77 : Abbreviations Used in this Report
Table 78 : Report Sources
Table 79 : Abbott: Company Snapshot
Table 80 : Abbott: Financial Performance, FY 2024 and 2025
Table 81 : Abbott: Product Portfolio
Table 82 : Abbott: News/Key Developments, 2024–2026
Table 83 : Baxter: Company Snapshot
Table 84 : Baxter: Financial Performance, FY 2024 and 2025
Table 85 : Baxter: Product Portfolio
Table 86 : Baxter: News/Key Developments, 2024
Table 87 : B. Braun SE: Company Snapshot
Table 88 : B. Braun SE: Financial Performance, FY 2024 and 2025
Table 89 : B. Braun SE: Product Portfolio
Table 90 : Danone: Company Snapshot
Table 91 : Danone: Financial Performance, FY 2024 and 2025
Table 92 : Danone: Product Portfolio
Table 93 : Danone: News/Key Developments, 2024–2026
Table 94 : dsm-firmenich: Company Snapshot
Table 95 : dsm-firmenich: Financial Performance, FY 2024 and 2025
Table 96 : dsm-firmenich: Product Portfolio
Table 97 : dsm-firmenich: News/Key Developments, 2024–2026
Table 98 : Fresenius Kabi AG: Company Snapshot
Table 99 : Fresenius Kabi AG: Financial Performance, FY 2024 and 2025
Table 100 : Fresenius Kabi AG: Product Portfolio
Table 101 : Fresenius Kabi AG: News/Key Developments, 2024–2025
Table 102 : Glanbia PLC: Company Snapshot
Table 103 : Glanbia PLC: Financial Performance, FY 2024 and 2025
Table 104 : Glanbia PLC.: Product Portfolio
Table 105 : International Flavors & Fragrances Inc.: Company Snapshot
Table 106 : International Flavors & Fragrances Inc.: Financial Performance, FY 2024 and 2025
Table 107 : International Flavors & Fragrances Inc.: Product Portfolio
Table 108 : Lonza: Company Snapshot
Table 109 : Lonza: Financial Performance, FY 2024 and 2025
Table 110 : Lonza: Product Portfolio
Table 111 : Meiji Holdings Co. Ltd.: Company Snapshot
Table 112 : Meiji Holdings Co. Ltd.: Financial Performance, FY 2024 and 2025
Table 113 : Meiji Holdings Co. Ltd.: Product Portfolio
Table 114 : Meiji Holdings Co. Ltd.: News/Key Developments, 2025–2026
Table 115 : Nestlé: Company Snapshot
Table 116 : Nestlé: Financial Performance, FY 2024 and 2025
Table 117 : Nestlé: Product Portfolio
Table 118 : Nestlé: News/Key Developments, 2026
Table 119 : Otsuka Holdings Co. Ltd.: Company Snapshot
Table 120 : Otsuka Holdings Co. Ltd.: Financial Performance, FY 2024 and 2025
Table 121 : Otsuka Holdings Co. Ltd.: Product Portfolio
Table 122 : Otsuka Holdings Co. Ltd.: News/Key Developments, 2024–2025
Table 123 : Perrigo Co. plc: Company Snapshot
Table 124 : Perrigo Co. plc: Financial Performance, FY 2024 and 2025
Table 125 : Perrigo Co. plc: Product Portfolio
Table 126 : Perrigo Co. plc: News/Key Developments, 2024
Table 127 : Prolacta: Company Snapshot
Table 128 : Prolacta: Product Portfolio
Table 129 : Prolacta: News/Key Developments, 2024–2026
Table 130 : Reckitt: Company Snapshot
Table 131 : Reckitt: Financial Performance, FY 2024 and 2025
Table 132 : Reckitt: Product Portfolio
Table 133 : Emerging Companies in the Global Clinical Nutrition Market
List of Figures
Summary Figure : Global Market Shares of Clinical Nutrition, by Region, 2025
Figure 1 : Porter’s Five Forces Analysis of the Global Clinical Nutrition Market
Figure 2 : Market Dynamics of Clinical Nutrition
Figure 3 : Distribution Share of the Most Frequent Cancer Types in Women*, 2022
Figure 4 : Distribution Share of the Most Frequent Cancer Types in Men*, 2022
Figure 5 : Estimated New Cancer Cases and Deaths in the U.S. in 2024
Figure 6 : Global Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
Figure 7 : Global Market Shares of Infant Nutrition in Clinical Nutrition, by Region, 2025
Figure 8 : Global Market Shares of Infant Nutrition in Clinical Nutrition, by Type, 2025
Figure 9 : Global Market Shares of Enteral Nutrition in Clinical Nutrition, by Region, 2025
Figure 10 : Global Market Shares of Enteral Nutrition in Clinical Nutrition, by Type, 2025
Figure 11 : Global Market Shares of Parenteral Nutrition in Clinical Nutrition, by Region, 2025
Figure 12 : Global Market Shares of Parenteral Nutrition in Clinical Nutrition, by Type, 2025
Figure 13 : Global Market Shares of Clinical Nutrition, by End User, 2025
Figure 14 : Global Market Shares of Clinical Nutrition for Infants, by Region, 2025
Figure 15 : Global Market Shares of Clinical Nutrition for Geriatrics, by Region, 2025
Figure 16 : Global Market Shares of Clinical Nutrition for Children, by Region, 2025
Figure 17 : Global Market Shares of Clinical Nutrition for Adults, by Region, 2025
Figure 18 : Global Market Shares of Clinical Nutrition, by Region, 2025
Figure 19 : North American Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
Figure 20 : North American Market Shares of Clinical Nutrition, by End User, 2025
Figure 21 : North American Market Shares of Clinical Nutrition, by Country, 2025
Figure 22 : U.S. Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
Figure 23 : U.S. Market Shares of Clinical Nutrition, by End User, 2025
Figure 24 : Canadian Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
Figure 25 : Canadian Market Shares of Clinical Nutrition, by End User, 2025
Figure 26 : Mexican Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
Figure 27 : Mexican Market Shares of Clinical Nutrition, by End User, 2025
Figure 28 : European Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
Figure 29 : European Market Shares of Clinical Nutrition, by End User, 2025
Figure 30 : European Market Shares of Clinical Nutrition, by Country, 2025
Figure 31 : German Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
Figure 32 : German Market Shares of Clinical Nutrition, by End User, 2025
Figure 33 : U.K. Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
Figure 34 : U.K. Market Shares of Clinical Nutrition, by End User, 2025
Figure 35 : French Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
Figure 36 : French Market Shares of Clinical Nutrition, by End User, 2025
Figure 37 : Italian Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
Figure 38 : Italian Market Shares of Clinical Nutrition, by End User, 2025
Figure 39 : Spanish Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
Figure 40 : Spanish Market Shares of Clinical Nutrition, by End User, 2025
Figure 41 : Rest of Europe Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
Figure 42 : Rest of Europe Market Shares of Clinical Nutrition, by End User, 2025
Figure 43 : Asia-Pacific Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
Figure 44 : Asia-Pacific Market Shares of Clinical Nutrition, by End User, 2025
Figure 45 : Asia-Pacific Market Shares of Clinical Nutrition, by Country, 2025
Figure 46 : Chinese Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
Figure 47 : Chinese Market Shares of Clinical Nutrition, by End User, 2025
Figure 48 : Japanese Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
Figure 49 : Japanese Market Shares of Clinical Nutrition, by End User, 2025
Figure 50 : Indian Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
Figure 51 : Indian Market Shares of Clinical Nutrition, by End User, 2025
Figure 52 : South Korean Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
Figure 53 : South Korean Market Shares of Clinical Nutrition, by End User, 2025
Figure 54 : Australian Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
Figure 55 : Australian Market Shares of Clinical Nutrition, by End User, 2025
Figure 56 : Rest of Asia-Pacific Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
Figure 57 : Rest of Asia-Pacific Market Shares of Clinical Nutrition, by End User, 2025
Figure 58 : Middle East and African Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
Figure 59 : Middle East and African Market Shares of Clinical Nutrition, by End User, 2025
Figure 60 : Middle East and African Market Shares of Clinical Nutrition, by Country, 2025
Figure 61 : Middle East Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
Figure 62 : Middle East Market Shares of Clinical Nutrition, by End User, 2025
Figure 63 : African Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
Figure 64 : African Market Shares of Clinical Nutrition, by End User, 2025
Figure 65 : South American Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
Figure 66 : South American Market Shares of Clinical Nutrition, by End User, 2025
Figure 67 : South American Market Shares of Clinical Nutrition, by Country, 2025
Figure 68 : Brazilian Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
Figure 69 : Brazilian Market Shares of Clinical Nutrition, by End User, 2025
Figure 70 : Argentine Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
Figure 71 : Argentine Market Shares of Clinical Nutrition, by End User, 2025
Figure 72 : Rest of South America Market Shares of Clinical Nutrition, by Type of Nutrition, 2025
Figure 73 : Rest of South America Market Shares of Clinical Nutrition, by End User, 2025
Figure 74 : Global Market Shares of Clinical Nutrition, by Company, 2025
Figure 75 : Abbott: Revenue Shares, by Business Unit, FY 2025
Figure 76 : Abbott: Revenue Shares, by Region/Country, FY 2025
Figure 77 : Baxter: Revenue Shares, by Business Unit, FY 2025
Figure 78 : Baxter: Revenue Shares, by Country/Region, FY 2025
Figure 79 : B. Braun SE: Revenue Shares, by Business Unit, FY 2025
Figure 80 : B. Braun SE: Revenue Shares, by Country/Region, FY 2025
Figure 81 : Danone: Revenue Shares, by Business Unit, FY 2025
Figure 82 : Danone: Revenue Shares, by Country/Region, FY 2025
Figure 83 : dsm-firmenich: Revenue Shares, by Business Unit, FY 2025
Figure 84 : Glanbia PLC: Revenue Shares, by Business Unit, FY 2025
Figure 85 : Glanbia PLC: Revenue Shares, by Country/Region, FY 2025
Figure 86 : International Flavors & Fragrances Inc.: Revenue Shares, by Business Unit, FY 2025
Figure 87 : International Flavors & Fragrances Inc.: Revenue Shares, by Country/Region, FY 2025
Figure 88 : Lonza: Revenue Shares, by Business Unit, FY 2025
Figure 89 : Lonza: Revenue Shares, by Country/Region, FY 2025
Figure 90 : Meiji Holdings Co. Ltd.: Revenue Shares, by Business Unit, FY 2025
Figure 91 : Nestlé: Revenue Shares, by Business Unit, FY 2025
Figure 92 : Nestlé: Revenue Shares, by Country/Region, FY 2025
Figure 93 : Otsuka Holdings Co. Ltd.: Revenue Shares, by Business Unit, FY 2025
Figure 94 : Perrigo Co. plc: Revenue Shares, by Business Unit, FY 2025
Figure 95 : Reckitt: Revenue Shares, by Business Unit, FY 2025
Figure 96 : Reckitt: Revenue Shares, by Country/Region, FY 2025